echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tan Desai calls for a two-month suspension of immunization of the new crown vaccine

    Tan Desai calls for a two-month suspension of immunization of the new crown vaccine

    • Last Update: 2021-09-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    On August 23, local time, the Director-General of the World Health Organization Tan Desai, who was visiting Hungary, called for a two-month suspension of inoculation of the new crown vaccine in order to reduce global vaccine inequality and prevent the emergence of new mutant new coronaviruses


    Tan Desai said that he was "very disappointed" by the uneven distribution of vaccines worldwide.


    Tan Desai called on countries preparing for the booster shot to share the vaccine with other countries to increase the coverage of their first and second doses of vaccine


    Focus on the new crown pneumonia epidemic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.